Literature DB >> 21515257

Short form of α9 promotes α9β1 integrin-dependent cell adhesion by modulating the function of the full-length α9 subunit.

Shigeyuki Kon1, Amha Atakilit, Dean Sheppard.   

Abstract

The α9β1 integrin is a multifunctional receptor that interacts with a variety of ligands including vascular cell adhesion molecule 1, tenascin-C, and osteopontin. A 2.3-kb truncated form of α9 integrin subunit cDNA was identified by searching the Medline database. This splice variant, which we called the short form of α9 integrin (SFα9), encodes a 632-aa isoform lacking transmembrane and cytoplasmic domains, and its authentic expression was verified by PCR and Western blotting. SFα9 is expressed on the cell surface but cannot bind ligand in the absence of the full-length α9 subunit. Over-expression of SFα9 in cells expressing full-length α9 promotes α9-dependent cell adhesion. This promoting effect of SFα9 requires the authentic cytoplasmic domain of the co-expressed full-length α9 subunit. Thus, SFα9 is a novel functional modulator of α9β1 integrin by inside-out signaling.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21515257      PMCID: PMC3118859          DOI: 10.1016/j.yexcr.2011.04.005

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  39 in total

1.  Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions.

Authors:  Koji Eto; Clotilde Huet; Takehiko Tarui; Sergey Kupriyanov; Hai-Zhen Liu; Wilma Puzon-McLaughlin; Xi-Ping Zhang; Dean Sheppard; Eva Engvall; Yoshikazu Takada
Journal:  J Biol Chem       Date:  2002-03-06       Impact factor: 5.157

2.  Real time analysis of the affinity regulation of alpha 4-integrin. The physiologically activated receptor is intermediate in affinity between resting and Mn(2+) or antibody activation.

Authors:  A Chigaev; A M Blenc; J V Braaten; N Kumaraswamy; C L Kepley; R P Andrews; J M Oliver; B S Edwards; E R Prossnitz; R S Larson; L A Sklar
Journal:  J Biol Chem       Date:  2001-10-18       Impact factor: 5.157

3.  The integrin alpha(9)beta(1) binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin.

Authors:  Y Yokosaki; N Matsuura; T Sasaki; I Murakami; H Schneider; S Higashiyama; Y Saitoh; M Yamakido; Y Taooka; D Sheppard
Journal:  J Biol Chem       Date:  1999-12-17       Impact factor: 5.157

4.  Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems.

Authors:  S Swift; J Lorens; P Achacoso; G P Nolan
Journal:  Curr Protoc Immunol       Date:  2001-05

5.  Binding of Paxillin to the alpha 9 Integrin Cytoplasmic Domain Inhibits Cell Spreading.

Authors:  S Liu; M Slepak; M H Ginsberg
Journal:  J Biol Chem       Date:  2001-07-27       Impact factor: 5.157

6.  The cytoplasmic domain of the integrin alpha9 subunit requires the adaptor protein paxillin to inhibit cell spreading but promotes cell migration in a paxillin-independent manner.

Authors:  B A Young; Y Taooka; S Liu; K J Askins; Y Yokosaki; S M Thomas; D Sheppard
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

7.  Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma.

Authors:  Meghan C Brown; Izabela Staniszewska; Philip Lazarovici; George P Tuszynski; Luis Del Valle; Cezary Marcinkiewicz
Journal:  Neuro Oncol       Date:  2008-12       Impact factor: 12.300

8.  The alpha9beta1 integrin enhances cell migration by polyamine-mediated modulation of an inward-rectifier potassium channel.

Authors:  Gregory W deHart; Taihao Jin; Diane E McCloskey; Anthony E Pegg; Dean Sheppard
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-14       Impact factor: 11.205

9.  Alpha9beta1 integrin in melanoma cells can signal different adhesion states for migration and anchorage.

Authors:  Magnus C Lydolph; Marie Morgan-Fisher; Anette M Høye; John R Couchman; Ulla M Wewer; Atsuko Yoneda
Journal:  Exp Cell Res       Date:  2009-09-29       Impact factor: 3.905

10.  Osteopontin is required for full expression of the transformed phenotype by the ras oncogene.

Authors:  Y Wu; D T Denhardt; S R Rittling
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

View more
  6 in total

1.  The novel α4B murine α4 integrin protein splicing variant inhibits α4 protein-dependent cell adhesion.

Authors:  Hitomi Kouro; Shigeyuki Kon; Naoki Matsumoto; Tomoe Miyashita; Ayaka Kakuchi; Dai Ashitomi; Kodai Saitoh; Takuya Nakatsuru; Sumihito Togi; Ryuta Muromoto; Tadashi Matsuda
Journal:  J Biol Chem       Date:  2014-04-22       Impact factor: 5.157

2.  The role of α9β1 integrin and its ligands in the development of autoimmune diseases.

Authors:  Shigeyuki Kon; Toshimitsu Uede
Journal:  J Cell Commun Signal       Date:  2017-10-03       Impact factor: 5.782

3.  Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications.

Authors:  Mehdi Azizi; Hassan Dianat-Moghadam; Roya Salehi; Masoud Farshbaf; Disha Iyengar; Samaresh Sau; Arun K Iyer; Hadi Valizadeh; Mohammad Mehrmohammadi; Michael R Hamblin
Journal:  Adv Funct Mater       Date:  2020-03-03       Impact factor: 18.808

Review 4.  Integrin-α9β1 as a Novel Therapeutic Target for Refractory Diseases: Recent Progress and Insights.

Authors:  Shihan Xu; Tingwei Zhang; Zhengguo Cao; Wenjie Zhong; Chuangwei Zhang; Han Li; Jinlin Song
Journal:  Front Immunol       Date:  2021-03-15       Impact factor: 7.561

5.  Secreted β3-integrin enhances natural killer cell activity against acute myeloid leukemia cells.

Authors:  Younis Skaik; Stefanie Vahlsing; Lilia Goudeva; Britta Eiz-Vesper; Anja Battermann; Rainer Blasczyk; Constança Figueiredo
Journal:  PLoS One       Date:  2014-06-11       Impact factor: 3.240

6.  The Phosphorylation and Distribution of Cortactin Downstream of Integrin α9β1 Affects Cancer Cell Behaviour.

Authors:  Anette M Høye; John R Couchman; Ulla M Wewer; Atsuko Yoneda
Journal:  Sci Rep       Date:  2016-06-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.